Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;113(1):126-142.
doi: 10.1007/s00223-023-01097-w. Epub 2023 Jun 1.

Examining Mechanisms for Voltage-Sensitive Calcium Channel-Mediated Secretion Events in Bone Cells

Affiliations
Review

Examining Mechanisms for Voltage-Sensitive Calcium Channel-Mediated Secretion Events in Bone Cells

Perla C Reyes Fernandez et al. Calcif Tissue Int. 2023 Jul.

Abstract

In addition to their well-described functions in cell excitability, voltage-sensitive calcium channels (VSCCs) serve a critical role in calcium (Ca2+)-mediated secretion of pleiotropic paracrine and endocrine factors, including those produced in bone. Influx of Ca2+ through VSCCs activates intracellular signaling pathways to modulate a variety of cellular processes that include cell proliferation, differentiation, and bone adaptation in response to mechanical stimuli. Less well understood is the role of VSCCs in the control of bone and calcium homeostasis mediated through secreted factors. In this review, we discuss the various functions of VSCCs in skeletal cells as regulators of Ca2+ dynamics and detail how these channels might control the release of bioactive factors from bone cells. Because VSCCs are druggable, a better understanding of the multiple functions of these channels in the skeleton offers the opportunity for developing new therapies to enhance and maintain bone and to improve systemic health.

Keywords: Bone secretion; Calcium homeostasis; Extracellular vesicles; Mechanosensation; Voltage-sensitive calcium channels.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Perla C. Reyes Fernandez, Christian S. Wright, Mary C. Farach-Carson, and William R. Thompson declare that there are no conflicts of interest.

Figures

Fig. 1
Fig. 1. VSCCs activate signaling pathways that directly or indirectly regulate bone cell secretion and function.
Upon mechanical stimulation, voltage-sensitive calcium channels (VSCCs) initiate a myriad of intracellular signaling events that result in the release of prostaglandin E2 (PGE2), ATP, and nitric oxide (NO). Secretion of these molecules activates various signaling pathways that alter gene expression and induce the synthesis of osteogenic and resorptive factors to modulate skeletal adaptation. Ca2+-influx via VSCCs also trigger release of intracellular Ca2+ from ER stores and activate downstream Ca2+-dependent pathways that regulate cell migration, proliferation, and differentiation. See text for reference. Straight line: Direct activation; Dotted line: Indirect activation. AA arachidonic acid; Akt protein kinase B; BMP2 Bone morphogenetic protein 2; CAM calmodulin: CAM; CAMK Ca2+/calmodulin-dependent protein kinase; CollA1 Collagen 1α1; COX-2 Cyclooxygenase-2; CRE cAMP-response elements; CREB cAMP-response element-binding protein; DAG Diacyl glycerol; Dlx5 Distal-Less Homeobox 5; eNOS endothelial nitric oxide synthase; NFATc nuclear factor of activated T cells c; NO nitric oxide; Ocn osteocalcin; OPG osteoprotegerin; OPN osteopontin; Osx osterix; PI3K phosphoinositide 3 kinase; PKA protein kinase A; PKC protein kinase C; PLA2 phospholipase A2; PLC phospholipase C. Figure was created using icons from BioRender.com
Fig. 2
Fig. 2. Proposed mechanism by which VSCCs might mediate extracellular vesicle release in bone cells.
Studies in other cell types suggest that VSCCs regulate EV release by initiating a localized increase in Ca2+. This increase controls docking and fusion of the machinery necessary for EV release. The Rab family of molecules and the SNARE motor assembly are also involved in coordinating various stages of vesicular transport. Therefore, by regulating Rab-mediated vesicular release, VSCCs could indirectly or directly influence bone cell function. Interaction of vesicles with VSCCs is enabled by Rab3 proteins through a series of molecular connections. Rab3 binds to Rab3-interacting molecules (RIMs) that then associate with RIMbinding proteins (RBPs). RBPs attach to the β subunit of VSCCs, enabling physical tethering of vesicles to VSCCs. Thus, control of Rab-mediated vesicular release is a means by which VSCCs could regulate bone cell function. Similarly, binding of Ca2+ to Synaptotagmin leads to vesicular fusion, while Ca2+-influx via VSCCs also triggers release of intracellular Ca2+ from ER stores to stimulate vesicular release. At the cell membrane, the α2δ1 subunit interacts with extracellular matrix molecules, including perlecan, representing a means by which this auxiliary subunit may scaffold various extracellular ligands to regulate EV release. These interactions could be important to initiate vesicular docking, secretion, and subsequent intercellular signaling. Finally, secreted microvesicles and exosomes containing molecular cargo act on bone cells to control their function and activity. Figure was created using icons from BioRender.com

References

    1. Burr DB, Allen MR (2019) Basic and applied bone biology. Academic Press, Cambridge
    1. Rosen CJ, American Society for Bone and Mineral Research (2013) Primer on the metabolic bone diseases and disorders of mineral metabolism. Wiley, Ames
    1. Eriksen EF (2010) Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11:219–227 - PMC - PubMed
    1. Xiao W, Wang Y, Pacios S, Li S, Graves DT (2016) Cellular and molecular aspects of bone remodeling. Tooth Mov 18:9–16 - PMC - PubMed
    1. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE (2001) Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047–4054 - PubMed

Publication types

LinkOut - more resources